论文部分内容阅读
交联琼脂痛包膜活性碳微囊(CAAC-Ⅱ)系重庆医科大学人工肝研究室1982年研制成功的一种新型人工肝辅助装置吸附剂。该室李非等以大鼠,豚鼠两种动物,经CAAC-Ⅱ血液灌流后,观察体内淋巴细胞转化、体外淋巴细胞转化以及外周血淋巴细胞数的变化,并将其与硅化玻珠血液灌流作对照进行比较,结果发现灌流时大鼠体内淋巴细胞转化的情况与豚鼠体外淋巴细胞转化的变化一致,提示体内淋巴细胞转化与体外淋巴细胞转化可能具有相似的意义,是检测细胞免疫的一种简便而实用的方法。
Crosslinked agar pain capsule activated carbon microcapsules (CAAC-Ⅱ) Department of Artificial Liver Laboratory of Chongqing Medical University in 1982 developed a new type of artificial liver auxiliary adsorbent. Li Fei and other non-rats to rats, guinea pigs two animals, after CAAC-Ⅱ hemoperfusion, observed in vivo lymphocyte transformation, lymphocyte transformation in vitro and peripheral blood lymphocyte number changes, and its silicagel beads blood perfusion As a control to compare the results found that the perfused rat lymphocyte transformation and guinea pig in vitro lymphocyte transformation consistent changes suggest that in vivo lymphocyte transformation and lymphocyte transformation in vitro may have similar significance is to detect a kind of cellular immunity Simple and practical way.